Janelle M
Neurologic and cognitive concerns (e.g., migraines) and neurodevelopmental symptoms: Findings are mixed across studies and effect sizes are generally small, so we interpret results cautiously and prioritize whole-person assessment over single-gene conclusions
Disponible : Gomez-Amores L, Mate A, Miguel-Carrosco J, Jimenez L, Jos A, Camean AM, Revilla E, Santa-Maria C, Vasquez C
In two phase 3 clinical trials involving more than 1,200 premenopausal women, PT-141 (bremelanotide) was shown to significantly improve sexual desire and reduce distress related to low desire compared with placebo ( Kingsberg et al., 2019, Obstetrics & Gynecology )
We tried it, but she didnt tolerate it she became nauseous and lost weight she didnt need. In this case, the risk outweighed the potential benefits, raising the question of whether GLP-1s offer the same longevity advantages for people without a medical indication for their use
Come join others currently navigating treatment in our weekly Virtual Support Groups
